Trial Summary
What is the purpose of this trial?
Conduct a study of people who use drugs (PWUD) perceptions of and access to COVID-19 vaccines as well as reasons for vaccine hesitancy/barriers
Research Team
Carl Latkin, PhD
Principal Investigator
Johns Hopkins Bloomberg School of Public Health
Eligibility Criteria
This trial is for people who have used opioids in the last two weeks. It's focused on understanding their views on COVID-19 vaccines, access to these vaccines, and what might be stopping them from getting vaccinated. There are no specific exclusion criteria listed.Inclusion Criteria
Opioid use in prior 2 weeks
Exclusion Criteria
Not applicable.
Treatment Details
Interventions
- Intervention test (Behavioral Intervention)
Trial OverviewThe study isn't testing a new drug or treatment. Instead, it's analyzing how people who inject drugs feel about COVID-19 vaccines and identifying any obstacles they face in getting vaccinated.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: ExperimentalExperimental Treatment1 Intervention
behavioral intervention
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Johns Hopkins Bloomberg School of Public HealthBaltimore, MD
Loading ...
Who Is Running the Clinical Trial?
Johns Hopkins Bloomberg School of Public Health
Lead Sponsor
Trials
441
Patients Recruited
2,157,000+
National Institutes of Health (NIH)
Collaborator
Trials
2896
Patients Recruited
8,053,000+